Evidence map›Paper›PMID 35742070›Full record

ArticleHealthcare (Basel, Switzerland)2022

Decision Conflicts in Clinical Care during COVID-19: A Patient Perspective.

Jörg Haier, Johannes Beller, Kristina Adorjan, Stefan Bleich, Moritz De Greck, Frank Griesinger, Alexander Hein, René Hurlemann, Sören Torge Mees, Alexandra Philipsen and 6 more

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Impact of the COVID-19 pandemic on oncological care in Germany: rapid review.Journal of cancer research and clinical oncology · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Jörg HaierComprehensive Cancer Center Hannover, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-1278-9438
Johannes BellerComprehensive Cancer Center Hannover, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-3041-9895
Kristina AdorjanDepartment of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich, 81377 Munich, Germany.
Stefan BleichDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, 30625 Hannover, Germany.
Moritz De GreckDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University Frankfurt am Main, 60528 Frankfurt, Germany.
Frank GriesingerDepartment of Hematology and Oncology, Pius-Hospital Oldenburg, Carl von Ossietzky University, 26129 Oldenburg, Germany.
Alexander HeinDepartment of Gynecology and Obstetrics, Erlangen University Hospital, 91054 Erlangen, Germany.ORCID 0000-0003-2601-3398
René HurlemannDepartment of Psychiatry, Carl von Ossietzky University, 26129 Oldenburg, Germany.
Sören Torge MeesDepartment of General, Visceral and Thoracic Surgery, Friedrichstadt General Hospital, 01067 Dresden, Germany.
Alexandra PhilipsenDepartment of Psychiatry and Psychotherapy, University Hospital Bonn, 53105 Bonn, Germany.
Gernot RohdeDepartment of Respiratory Medicine and Allergology, University Hospital, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-5193-7755
Georgia SchillingDepartment of Hematology, Oncology, Palliative Care and Rheumatology, Asklepios Hospital Altona, Asklepios Tumorzentrum, 22763 Hamburg, Germany.
Karolin TrautmannDepartment of Hematology and Oncology, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Stephanie E CombsDepartment of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
Siegfried GeyerMedical Sociology Unit, Hannover Medical School, 30625 Hannover, Germany.
Jürgen SchäfersComprehensive Cancer Center Hannover, Hannover Medical School, 30625 Hannover, Germany.
Medizinische Hochschule Hannover · DEGoethe University Frankfurt · DEAsklepios Klinik Altona · DECarl von Ossietzky Universität Oldenburg · DEKrankenhaus Dresden-Friedrichstadt · DELudwig-Maximilians-Universität München · DEPius Hospital Oldenburg · DETUM Klinikum · DEUniversitätsklinikum Erlangen · DEUniversity Hospital Bonn · DEUniversity Hospital Carl Gustav Carus · DE

Funding

Federal Ministry of Education and Research 01KI2098A ; 01KX2021
6 · The paper itself

Abstract

(1) Background: Uncertainty is typical for a pandemic or similar healthcare crisis. This affects patients with resulting decisional conflicts and disturbed shared decision making during their treatment occurring to a very different extent. Sociodemographic factors and the individual perception of pandemic-related problems likely determine this decisional dilemma for patients and can characterize vulnerable groups with special susceptibility for decisional problems and related consequences. (2) Methods: Cross-sectional data from the OnCoVID questionnaire study were used involving 540 patients from 11 participating institutions covering all major regions in Germany. Participants were actively involved in clinical treatment in oncology or psychiatry during the COVID-19 pandemic. Questionnaires covered five decision dimensions (conflicts and uncertainty, resources, risk perception, perception of consequences for clinical processes, perception of consequences for patients) and very basic demographic data (age, gender, stage of treatment and educational background). Decision uncertainties and distress were operationalized using equidistant five-point scales. Data analysis was performed using descriptive and various multivariate approaches. (3) Results: A total of 11.5% of all patients described intensive uncertainty in their clinical decisions that was significantly correlated with anxiety, depression, loneliness and stress. Younger and female patients and those of higher educational status and treatment stage had the highest values for these stressors (p < 0.001). Only 15.3% of the patients (14.9% oncology, 16.2% psychiatry; p = 0.021) considered the additional risk of COVID-19 infections as very important for their disease-related decisions. Regression analysis identified determinants for patients at risk of a decisional dilemma, including information availability, educational level, age group and requirement of treatment decision making. (4) Conclusions: In patients, the COVID-19 pandemic induced specific decisional uncertainty and distress accompanied by intensified stress and psychological disturbances. Determinants of specific vulnerability were related to female sex, younger age, education level, disease stages and perception of pandemic-related treatment modifications, whereas availability of sufficient pandemic-related information prevented these problems. The most important decisional criteria for patients under these conditions were expected side effects/complications and treatment responses.

Indexed as

COVID-19decision conflictsmoral distressoncologypsychiatryuncertainty

Identifiers

PMID35742070
PMCPMC9222354
OpenAlexW4281702467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.